The role of luminal factors in the recovery of gastric function and behavioral changes after chronic Helicobacter pylori infection

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 295, Issue 4, 2008, Pages

  Verdu, Elena F ^a   Bercik, Premysl ^a   Xian, Xi Huang ^a   Lu, Jun ^a   Al Mutawaly, Nafia ^a   Sakai, Hiromi ^b   Tompkins, Thomas A ^c   Croitoru, Kenneth ^a   Tsuchida, Eihun ^b   Perdue, Mary ^a   Collins, Stephen M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b WASEDA UNIVERSITY   (Japan)

^c LALLEMAND SAS   (France)

Author keywords

Feeding patterns; Gastric emptying; Lactobacilli

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; BAGG ALBINO MOUSE; CD3 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEEDING BEHAVIOR; FLUOROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; JEJUNUM; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH EMPTYING; STOMACH FUNCTION; T LYMPHOCYTE; VIDEOFLUOROSCOPY; VIDEORECORDING;

ANIMALS; ANTIGENS, BACTERIAL; CHRONIC DISEASE; DYSPEPSIA; FEEDING BEHAVIOR; GASTRIC EMPTYING; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; LACTOBACILLUS HELVETICUS; LACTOBACILLUS RHAMNOSUS; MALE; MICE; MICE, INBRED BALB C; PROBIOTICS; STOMACH;

EID: 57349088705     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90316.2008     Document Type: Article

References (25)

1. Bercik P, Armstrong D, Emde C, Dutoit P, Fraser R, Blum AL, Kucera P. Origin of rhythmic motility patterns in arterially perfused rat intestine. Gastroenterology 106: 649-657, 1994.
2. Bercík P, De Giorgio R, Blennerhassett P, Verdú EF, Barbara G, Collins SM. Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology 123: 1205-1215, 2002.
3. Bercik P, Wang L, Kean I, Verdu EF, Tougas G, Collins SM. Persistence of sensory and eating disturbances after H. pylori eradication in mice. Gastroenterology 122: W1074, 2002. (Abstract)
4. Blum AL, Talley NJ, O'Morrain C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. Omeprazole plus clarithromycin and amoxicillin effect one year after treatment (OCAY) study group. N Engl J Med 339: 1875-1881, 1998.
5. Di Leo V, D'Inca R, Bettini MB, Podswiadek M, Punzi L, Mastropaolo G, Sturniolo GC. Effect of Helicobacter pylori and eradication therapy on gastrointestinal permeability. Implications for patients with seronegative spondyloarthritis. J Rheumatol 32: 295-300, 2005.
6. Fedwick JP, Lapointe TK, Meddings JB, Sherman PM, Buret AG. Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability. Infect Immun 73: 7844-52, 2005.
7. Graham DY, Klein PD. Campylobacter pyloridis gastritis: the past, the present and speculations about the future (Review). Am J Gastroenterol 82: 283-286, 1987.
8. Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ, Read NW. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 347: 150-153, 1996.
9. Jiang B, Jordana M, Xing Z, Smaill F, Snider DP, Borojevic R, Steele-Norwood D, Hunt RH, Croitoru K. Replication-defective adenovirus infection reduces Helicobacter felis colonization in the mouse in a gamma interferon- and interleukin-12-dependent manner. Infect Immun 67: 4539-4544, 1999.
10. Johnson-Henry KC, Mitchell DJ, Avitzur Y, Galindo-Mata E, Jones NL, Sherman PM. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci 49: 1095-1102, 2004.
11. Malfertheiner P, Fischbach W, Layer P, Moessner J, Stolte M, Leodolter A, Demleitner K, Fuchs WA. ELAN study proves symptomatic benefit of Helicobacter pylori eradication in functional dyspepsia. Gastroenterology 118: A440, 2000. (Abstract)
12. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM, Walkerton Health Study Investigators. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 131: 445-450, 2006.
13. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 16: 1311-1315, 1984.
14. Matysiak-Budnik T, Hashimoto K, Heyman M, de Mascarel A, Desjeux JF, Mégraud F. Antral gastric permeability to antigens in mice is altered by infection with Helicobacter felis. Eur J Gastroenterol Hepatol 11: 1371-1377, 1999.
15. Matysiak-Budnik T, Terpend K, Alain S, Sanson le Pors MJ, Desjeux JF, Mégraud F, Heyman M. Helicobacter pylori alters exogenous antigen absorption and processing in a digestive tract epithelial cell line model. Infect Immun 66: 5785-5791, 1998.
16. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 339: 1869-1874, 1998.
17. Mearin F, Pérez-Oliveras M, Perelló A, Vinyet J, Ibañez A, Coderch J, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 129: 98-104, 2005.
18. Sakai H, Sou K, Horinouchi H, Kobayashi K, Tsuchida E. Hemoglobin vesicles as artificial oxygen carriers: present situation and future visions. J Intern Med 263: 4-15, 2008.
19. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47: 804-811, 2000.
20. Tack J, Demedts I, Dehondt G, Caenepeel P, Fischler B, Zandecki M, Janssens J. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 122: 1738-1747, 2002.
21. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 mo' follow up. The optimal regimen cures Helicobacter induced dyspepsia (ORCHID) study group. BMJ 318: 833-837, 1999.
22. Talley NJ, Vakil N, Ballard ED 2nd, Fenerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. N Engl J Med 341: 1106-1111, 1999.
23. Varghese AK, Verdú EF, Bercik P, Khan WI, Blennerhassett PA, Szechtman H, Collins SM. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology 130: 1743-1753, 2006.
24. Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 53: 1096-1101, 2004.
25. Zareie M, Johnson-Henry K, Jury J, Yang PC, Ngan BY, McKay DM, Soderholm JD, Perdue MH, Sherman PM. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55: 1553-1560, 2006.